Tafasitamab Antibody
Tafasitamab is an Fc-engineered, humanized monoclonal antibody directed against CD19. It is a research tool for investigating B-cell malignancies, particularly diffuse large B-cell lymphoma (DLBCL), in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
Apoptosis, CD19, MOR 00208, MOR00208, MOR-00208, Immunology related, Immunologyrelated, Inflammationrelated, Inflammation related, XmAb5574, Tafasitamab, Tafasitamab-cxix
Target
Immunology/Inflammation related, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
2.39 mg/mL
Purity
95.50% (May vary between batches)
Molecular Weight
147.41 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A21397-10mM-D 10 mM x 1mL in DMSO
CP-409092 hydrochloride 10mM * 1mL in DMSO
Sign In for Pricing
View Details PB9870-Dylight550 100 µg
Anti-Filaggrin/FLG Antibody Picoband® (Dylight550 Conjugate)
Sign In for Pricing
View Details NBP2-41406 0.1 mg
Mouse Monoclonal Myeloperoxidase/MPO Antibody (MPO421-8B2)
Sign In for Pricing
View Details